Central nervous system (CNS) regeneration with central neuronal connections and restoration of synaptic connections has been a long-standing worldwide problem and, to date, no effective clinical therapies are widely accepted for CNS injuries. The limited regenerative capacity of the CNS results from the growth-inhibitory environment that impedes the regrowth of axons. Central neural tissue engineering has attracted extensive attention from multi-disciplinary scientists in recent years, and many studies have been carried out to develop cell-and regenerationactivating biomaterial scaffolds that create an artificial micro-environment suitable for axonal regeneration. Among all the biomaterials, hyaluronic acid (HA) is a promising candidate for central neural tissue engineering because of its unique physico-chemical and biological properties. This review attempts to outline current biomaterials-based strategies for CNS regeneration from a tissue engineering point of view and discusses the main progresses in research of HA-based scaffolds for central neural tissue engineering in detail.
INTRODUCTION
Damage to the central nervous system (CNS) including the brain and the spinal cord, which is mostly caused by trauma, tumour or disease, usually results in severe neurological impairments with irretrievable nervous system functional devastations or limitations such as paralysis, limited mobility and sensory loss. In China, it is roughly estimated that more than 1 500 000 people live with spinal cord injury (SCI), and there are approximately 10 000 new cases every year. Therefore, functional recovery of injured CNS has been extremely significant in clinical cases for improving the qualities of patients' lives.
Unlike peripheral nervous system (PNS) injury, completely functional restoration in damaged CNS is not possible in most clinical cases. Consequently, CNS regeneration with central neuronal connections and restoration of synaptic connections has been a longstanding worldwide problem, which has attracted extensive attention from multi-disciplinary scientists. The CNS has limited capacity for regeneration mainly because of the growth-inhibitory environment that impedes the regrowth of axons. Owing to injuries, a series of complex cellular and biochemical reactions are triggered within the CNS and they are usually divided into two phases: primary injury and secondary injury. Primary injury is an acute phase of injury that is caused by contusion, laceration, compression or severe rotation of the tissue, transection of axons and local blood vessel damage, and finally it leads to cell necrosis at the injury epicentre [1, 2] . Except for direct cell death and haemorrhage, there is no more damage to the CNS caused by the primary injury [3] . However, the advent of secondary injury slowly deteriorates the condition, resulting in complete and permanent trauma to cells and axons, and functional disabilities in the CNS. Secondary injury is the chronic phase injury, which lasts several months or years. After injury, owing to death of neural cells, breakdown of blood-brain barrier and influx of inflammatory cells, reactive gliosis is initiated and glial scars are formed [4] . Although, at the beginning, glial scars seclude the injury site from the healthy tissue and play an important role in restoration of the bloodbrain barrier, they finally develop into a tenacious and rubbery membrane acting as a physical barrier that blocks the outgrowth, penetration and reconnection of axons [5] . Besides this physical barrier, in the glial scar, there are several kinds of molecules that act as a biochemical barrier, including Nogo, myelin-associated glycoprotein (Mag), oligodendrocyte myelin glycoprotein (Omgp) and chondroitin sulphate proteoglycan (CSPG), all of which have been demonstrated to be potent inhibitors of neurite outgrowth [6] [7] [8] [9] [10] [11] [12] [13] .
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Based on the knowledge of physiology of the CNS and pathology of CNS injuries, the main factors that deprive the CNS of the ability to regenerate are multi-faceted and can be summarized as: inability of adult neurons to proliferate; absence of neurotrophic factors; formation of glial scars; existence of inhibitory molecules. To date, no effective clinical therapies are widely accepted for CNS injuries, although some are commonly applied, including methylprednisolone treatment and cell therapy, both of which fail to achieve complete recovery because they overcome only some but not all of the inhibitory factors. Hence, a multifaceted approach is needed to design and produce a system that integrates several factors to conquer all the inhibitory factors. Tissue engineering uses scaffolds, living cells and regulators to develop ideal biological substitutes for restoring or regenerating damaged body tissues. Consequently, by integrating the use of biomaterials, cells and regulators, such tissue engineering strategy sheds new light on CNS regeneration. Since it is biomaterials (scaffolds) that play a critical role in tissue engineering by acting as biodegradable engineered extracellular matrix (ECM) for in vitro or in vivo cell attachment, proliferation, migration, differentiation and tissue formation, the key to successful CNS regeneration with tissue engineering approaches lies in developing materials-based strategies to overcome the inhibitory environment. Recently, higher requirements are raised in bioactivity of materials [14, 15] . Instead of merely being able to promote cell adhesion, migration and proliferation, the truly bioactive materials are expected to be capable of inducing certain cellular responses and activating certain gene expressions in the patient's tissue, so as to make use of their self-healing potential. These ideal properties are underlaid by a special design of the biomaterial system and it is up to the materials scientists to achieve this goal with multi-disciplinary knowledge.
Here in this review, we first summarize current biomaterials-based strategies for central neural tissue engineering, and then we focus on recent progress in designing and fabricating hyaluronic acid (HA)-based scaffolds.
CURRENT BIOMATERIALS-BASED STRATEGIES FOR CENTRAL NERVOUS SYSTEM REGENERATION FROM A TISSUE ENGINEERING POINT OF VIEW
As we all know, tissue engineering triad consists of scaffolds, cells and regulators (biomolecules), all of which are quite critical for tissue repair or regeneration. However, cells and/or biomolecules are thought to be not definitely necessary to be loaded into scaffolds and cultured for a while in vitro before transplantation. Hydrogels are three-dimensional networks of hydrophilic polymer held together by chemical or physical cross-linking. Hydrogels are glassy in the dry state but they swell in water and form elastic gels, retaining a large quantity of water in their mesh-like structures. Many kinds of hydrogels have been used and they can be classified into naturally derived hydrogels, namely HA, chitosan, alginate, agarose, fibrin, and methylcellulose, and synthetic hydrogels, namely poly(2-hydroxyethyl methacrylate), poly[N-(2-hydroxypropyl) methacrylamide] and polyethylene glycol. Made of polysaccharides, glycosaminoglycans or ECM constituents, naturally derived hydrogels are inherently bioactive and allow for cell attachment. Besides, under physiological conditions, naturally derived hydrogels are degradable via enzymatic action, which facilitates infiltration of cells and axons into the hydrogels [16] . However, batch variation and the risk of disease transmission may limit the application of naturally derived hydrogels. For synthetic hydrogels, they are biologically inert and cells hardly adhere to them, which makes it necessary to adopt modification such as tethering of natural polymers or adhesive motifs.
Electrospinning is effective in producing fine fibres of nanoscale diameters that range from several nanometres to 1 mm [17] . Made of nanofibrous meshes, electrospun scaffolds exhibit high surface-to-volume ratio and high porosity, and thus mimic the hierarchical structures of laminin and collagen of the ECM, which facilitates cell and axon penetration, offers guidance cues to neurite extension and enhances scaffold-tissue integration. A lot of polymers have been employed to produce electrospun fibres, including chitosan [18] , poly-L-lactic acid (PLLA) [19, 20] , polycaprolactone (PCL) [21] , polylactic-glycolic acid (PLGA) [22] , polyether sulphone [23] , poly(L-lactic acid)-co-poly(3-caprolactone) [24] and polyurethane [25] .
Self-assembly is another method for producing nanofibre networks. Via hydrophobic interaction, oligopeptides or amphiphilic peptides assemble into self-assembling peptide nanofibre scaffolds (SAPNSs), with hydrophobic backbones forming the core, and the hydrophilic head groups forming the sheath [26] . Compared with electrospun fibres, SAPNSs more closely mimic the hierarchical structure of ECM owing to smaller fibre diameters and high-density presentation of peptide sequences.
In order to enhance neural regeneration, many studies have been conducted to optimize the design and fabrication of scaffolds. The effect of modulus of elasticity, architectural structures and modification with ECM components has been extensively investigated.
Modulus of elasticity of scaffolds
Modulus of elasticity of scaffolds has recently been shown to be a key factor that influences cell behaviours. Different adhesion and morphologies of astrocytes and neurons in response to changes in modulus were observed [27] . Soft gels tended to suppress the adhesion and proliferation of astrocytes, while modulus did not significantly alter the actin formation and neurite extension. In cultures of dissociated embryonic cortices, it was further demonstrated that the control of modulus was effective in screening the cells that attached onto the surface. Moreover, modulus was reported to be able to direct stem cells into different lineages. Mesenchymal stem cells (MSCs) were directed into neurogenic lineages when they were cultured on soft gels that had modulus similar to that of brain tissue [28] . Neural stem cells (NSCs) favoured neuronal lineages on soft gels with modulus less than 1 kPa [29, 30] . Thus, modulus should be paid attention to when scaffolds are designed and prepared. Hydrogels with modulus similar to that of the brain or spinal cord tissue are ideal for use in CNS regeneration.
Architecture
There have been many studies on repair of the PNS by tubes or nerve guides, with some promising results observed [31, 32] . These anisotropic structures offer physical guidance to the migration of cells and the penetration of axons. Thus, in CNS studies, uniaxial structures are prepared and the effects of guidance cues are investigated.
There are several ways to create uniaxial structures with hydrogels. Templating, which is straightforward and reproducible, is highly effective in fabricating scaffolds with longitudinal channels [33] . After removal of PCL fibres by acetone, uniaxial channels are formed where PCL fibres had been. Thus, the sizes of the channels can be directly controlled by the diameter of the fibres. It is reported that the implantation of templated agarose scaffolds resulted in linear and organized penetration of axons and blood vessels, in distinction to the random orientation without scaffolds [34] . However, an in vivo study surprisingly showed that channels with different diameters did not differ in their ability to support axon migration [35] . Moreover, the tubular structure is far from perfect. Wong et al. [36] highlighted the importance of microstructures. In this study, the effect of scaffolds with different complex structure was studied, demonstrating that open-path designs better promoted axonal regeneration, while closed designs resulted in the encapsulation of fibrous tissues and the enlargement of defects. Freeze-drying is another way to fabricate uniaxial hydrogel scaffolds [37, 38] . With a gradient in temperature, scaffolds with honeycomb structure were created [38] . Along with other factors, linear growth of axons within channels was observed and the axons successfully bridged the lesion.
Many studies have shown that the orientations of electrospun nanofibres are vital in controlling cell behaviours. Aligned electrospun fibres are mainly fabricated by collecting the polymer stream at a metal grounded drum or plate that rotates at a suitable speed [19, [39] [40] [41] . It was reported that the orientation of neurite extension was highly dependent on the fibres [20] . Further analysis measuring the length of neurites showed that the aligned fibres increased neurite extension by 20 per cent in length compared with random controls. This effect was more vividly shown by samples combining both random controls and aligned fibres [42] . At the border of aligned and random nanofibres, the neurites from the same dorsal root ganglion (DRG) cells grew without any preference in direction on the side of random fibres, while on the other side where electrospun fibres were aligned, they grew along the fibre alignment; apparently, the neurites were much longer on aligned fibres. If pluripotent cells were incorporated, the alignment was shown to influence cell differentiation, with more cells being induced towards neuronal lineages on aligned fibres for mouse embryonic stem cells (ESCs) [21] and MSCs [43] .
Modification of engineered extracellular matrix components
The ECM molecules are important components of the nervous system. Composed of a heterogeneous lattice of proteoglycans and glycoproteins, ECM provides structural support and anchorage for cells and regulates cell adhesion, migration and proliferation [44] . Among all the ECM molecules, laminin and fibronectin, together with their peptide motifs, have been recognized to facilitate nerve development and offer a neuroprotective function in the nervous system after injury [45] [46] [47] . Thus, laminin, fibronectin, collagen and their peptide motifs have been used to modify scaffolds, so as to improve cell adhesion and axon sprouting, and enhance neural regeneration.
Incorporation of whole ECM molecules, either by coating, blending, covalently immobilizing, or as fillers in tubes, makes scaffolds more biocompatible, especially for synthetic scaffolds that lack bioactive domains to interact with cells. Modification with laminin, either by covalent binding, physical adsorption or blending, was observed to significantly enhance neurite extension compared with negative controls [48] . In this study, blending was shown to be more effective than covalent binding and physical adsorption, which might result from the higher laminin quantity coupled to PLLA nanofibres by blending. The function of collagen in promoting spinal cord regeneration was investigated in vivo [49] . One year after implantation, regeneration of axon and functional recovery were achieved in groups with chitosan tubes filled by semifluid type I collagen. This modification stimulated regenerative nerve fibres to penetrate the lesion site and grow into the distal end, while this effect was not observed in negative controls. The incorporation of ECM components may influence differentiation of pluripotent cells, but it is still debatable and extensive studies are needed [50, 51] .
Peptides of laminin, collagen and fibronectin are alternative ECM molecules in modification of scaffolds. Arg -Gly -Asp (RGD), Ile -Lys -Val-Ala -Val (IKVAV) and Tyr-Ile -Gly -Srg-Arg (YIGSR) are the most widely used. Modification of YIGSR better enhanced neurite extension compared with control groups without YIGSR both in vitro and in vivo [52] . Similar results were reported in studies on modification of RGD and IKVAV [53, 54] . Schense et al. [55] systematically investigated the effect of peptide concentration and combination on neurite extension. Not all peptides had linear relationships between neurite outgrowth and incorporated peptide concentration. Different co-crosslinked peptides elicited various effects on the neurite extension, depending on the combination.
Regulators
Delivery of antibodies, neurotrophic factors or therapeutic drugs to lesion sites in the CNS can alleviate inflammation, protect spared tissue around the lesion and promote neural regeneration. Direct injections of these bioactive molecules have a relatively short half-life [56] ; thus, scaffolds are used to achieve sustained release of bioactive molecules. Here, we limit our discussion to the scaffold-based delivery of neurotrophic factors and therapeutic drugs, while delivery of antibodies will be discussed in §3.4.
Delivery of neurotrophic factors
Some of the most commonly used growth factors to promote neural regeneration are neurotrophic factors, including nerve growth factor (NGF) [57] , neurotrophin-3 (NT-3) [58], brain-derived neurotrophin factor (BDNF) [59] , glial cell line-derived neurotrophic factor (GDNF) [60] and ciliary neurotrophic factor (CNTF) [61] . Different methods have been developed to deliver these growth factors, namely physical embedding, heparin-binding and covalent-binding.
Physical embedding is a simple method to deliver neurotrophic factors. Factors are blended with hydrogel solution and they evenly distribute within the hydrogel scaffolds after gelation [62, 63] . Delivery of GDNF in this way resulted in promotion of axonal outgrowth and suppression of cystic cavitation [62] . To prolong the in vivo availability and reduce running away, carriers are introduced to deliver growth factors. It was shown that the dosage of NT-3 to induce NSCs to commit neuronal lineages was much lower in the groups employing chitosan carriers, compared with those of direct addition [64] .
Sakiyama-Elbert et al. developed a heparin-based delivery system for sustained release of growth factors. This system has been successfully applied to deliver b-fibroblast growth factor [65] , NGF [66] , plateletderived growth factor [67] and NT-3 [68] . The potential of this heparin-based delivery system for use in repairing CNS injuries was investigated in vivo [58] . Despite some promising results in the short term, functional recovery study between a group with heparin-NT-3 and a negative control did not show a significant difference after 12 weeks, indicating that from a clinical point of view, the time period for growth factor delivery should be further prolonged.
Recently, many studies tried to covalently immobilize neurotrophic factors onto scaffolds. Compared with physical adsorption, a higher concentration of growth factors was obtained via immobilization [69] . Instead of compromising the bioactivity, immobilization in fact increased the efficacy of growth factors [57] . It was reported that immobilization of vascular endothelial growth factor (VEGF) outperformed in cell adhesion and viability even at a much lower concentration compared with soluble VEGF [70] . Thus, immobilization of neurotrophic factors increases the efficiency, reduces the required dosage and makes it possible to provide a long-term delivery.
Delivery of therapeutic drugs
Methylprednisolone, which is capable of improving neurologic recovery, is widely used for acute SCI. However, high doses of methylprednisolone increase the risk of unwanted side effects. So it is imperative to find an effective way to deliver methylprednisolone to lesion sites in doses as small as possible. A delivery system was developed to provide a sustained release of methylprednisolone [71] . Methylprednisolone was encapsulated in PLGA nanoparticles embedded in agarose hydrogels. Results showed that this system successfully delivered methylprednisolone to injured spinal cord tissue without compromising its bioactivity. The inflammation and cystic cavitation were significantly reduced owing to the presence of methylprednisolone.
Cells
Several cell types have been used for CNS injury studies, including Schwann cells (SCs) [72] , hippocampal neurons [73] , DRGs [74] , olfactory ensheathing cells (OECs) [75] , NSCs [76, 77] , neural progenitor cells (NPCs) [67] , ESCs [51] and MSCs [78, 79] .
In many studies, cell -scaffold complexes are fabricated and implanted into CNS lesion sites to evaluate their abilities in inducing neural regeneration. It was observed that implantation of such cell -scaffold complexes resulted in suppression of inflammation and astrocytic scarring around the lesion [80] [81] [82] , reduction of lesion volume [78] , infiltration of regenerating axons into the implant [80, 82, 83] , ingrowth of new blood vessels [82, 83] , formation of synapses [84] and even functional recovery [78, 83, 85] .
To further enhance regeneration, cell co-culture system is introduced. Co-culture of endothelial cells and NPCs led to enhanced formation of tubular structures [86] . After implantation into lesions in spinal cord, the coculture implant was found to be highly effective in promoting angiogenesis, with a twofold increase in functional vessels over the implant with endothelial cells alone [87] . Since OECs and SCs are important cells that ensheath axons, co-culture of SCs with NSCs/NPCs may further enhance axonal formation and infiltration compared with encapsulation of either cells alone.
RESEARCH OF HYALURONIC ACID-BASED SCAFFOLDS FOR CENTRAL NERVOUS SYSTEM REGENERATION
As discussed earlier, different kinds of biomaterials have been investigated for their potential in promoting axonal regeneration. Among them, HA is one of the best candidates for the following reasons: as a major component of soft connective tissue, HA is widely found in most organs and tissues [88, 89] , especially in the CNS [90] ; owing to its high biocompatibility, HA plays a beneficial role in wound healing [91, 92] ; in recent studies, it has been shown that implantation of HA scaffolds reduces glial scar formation [93, 94] . To further enhance axonal regeneration with HA scaffolds, a series of strategies are implemented, and promising results are observed [95, 96] . Here, we briefly discuss recent progress on the researches of HA-based scaffolds for CNS regeneration.
Pure hyaluronic acid hydrogels as scaffolds for central nervous system regeneration
HA hydrogels have an interconnected porous structure (figure 1) [94] that allows transportation of nutrition and penetration of cells, nerve fibres and blood vessels. Thus, HA hydrogels are used as implants to enhance neural regeneration. HA was demonstrated to be effective in reducing scar formation and enhancing neural regeneration in both the PNS [97] and CNS [98] . An in vivo study showed that treatment with HA hydrogels significantly inhibited glial scarring, with much smaller gliosis thickness and fewer glial fibrillary acidic protein (GFAP)-positive cells around the scarring area [98] . However, according to a recent study, only HA hydrogels with high molecular weight had such an effect to inhibit astrocytic activation, macrophage/microglia infiltration and CSPG deposition [99] . It was hypothesized that this effect resulted from interaction between HA and certain receptors via different states of aggregation [100] . However, further experiments are essential to confirm the results because in the original study, a control group treated with low molecular weight HA was absent, where the influence of low molecular weight cannot directly be shown. Besides molecular weight, the modulus of HA hydrogels was reported to be capable of influencing differentiation of NPCs [101] . The majority of NPCs cultured in hydrogels with similar modulus to that of neonatal brain tissue differentiated into neurons with extended long processes, while those cultured in hydrogels with similar modulus to that of adult brain tissue mostly differentiated into astrocytes.
Hyaluronic acid hydrogels blended with other materials as scaffolds for CNS regeneration
A dominant disadvantage of HA is that cells do not adhere to its surface. Hence, HA hydrogels were blended with other materials to promote cell adhesion and thus enhance neural regeneration. Spector and his colleague reported that blending HA with collagen enabled the fabrication of scaffolds with suitable mechanical properties for CNS regeneration [102] . In vitro experiments showed that the NSCs cultured in HAcollagen scaffolds favoured neuronal differentiation, which was in accordance with the results reported by Forsberg-Nilsson and co-workers [103] .
Modification of hyaluronic acid hydrogels
Another way to promote cell adhesion is modifying HA hydrogels with ECM components, namely laminin, RGD, IKVAV, poly-D-lysine (PDL) and poly-L-lysine (PLL). Our group reported that the modification of HA with laminin better improved tissue reconstruction than that of negative controls [104] . Figure 2a ,b, shows the reactive astrocytes around the boundary of the host tissues and the HA hydrogel scaffold by immunostaining after 12 weeks. Fewer GFAP-positive astrocytes were found in the groups with laminin modification. Statistical analysis showed that after 12 weeks, modification of laminin reduced one-third of astrocytes around the boundary. Silver staining revealed the presence of argyrophilic processes that grew into the HA scaffolds in the modified groups (figure 2c), not only around the boundary of the lesion site, but also into the epicentre of the lesion, while no such processes were found in the unmodified counterpart (figure 2d ). However, laminin modification did not affect the new blood formation. Hence, HA hydrogels modified with laminin improved neural regeneration mainly by reducing reactive astrocytes gathering around the lesion boundary and promoting new fibre formation within the scaffolds. Besides laminin, special domains of laminin such as RGD and IKVAV were immobilized to HA hydrogels to promote cell adhesion. RGD modification was demonstrated to significantly enhance cell migration into implants (figure 3), finally resulting in the formation of collagen-like bundles and neurofibrils in the hydrogel implants [53] . IKVAV modification was demonstrated to have similar effects [105] . Modification with ECM proteins or peptides makes it possible for cells to adhere to HA hydrogels, which facilitates HA scaffolds to serve as a promising candidates for cell delivery in stem cell therapies for neural regeneration.
PDL is frequently used as a coating material before cultures of neuronal cells [106] . In order to make HA an effective substrate for axonal extension, lysine was covalently bound to HA and it was found that PDL modification was effective in promoting cell adhesion and migration [93] . Rat cortical cells failed to attach to untreated HA hydrogels even after 5 days of culture in serum-containing medium, while in PDL-treated groups cells adhered to HA hydrogels and formed interconnected networks, as shown in figure 4 . In a traumatic brain injury rat model, groups implanted with PDL-treated HA hydrogels showed improved regeneration of blood vessels and reconstruction of new ECM. These results further demonstrated that PDLmodification was effective in making HA hydrogels more biocompatible and promoting angiogenesis.
3.4. Delivery of bioactive agents using hyaluronic acid-based scaffolds 3.4.1. Delivery of Nogo receptor antibodies using hyaluronic acid-based scaffolds Studies have shown that the three axonal growth inhibitors Nogo, Mag and Omgp require interactions with Nogo receptor (NgR) to exert their inhibitory influence [107] [108] [109] , and blocking of NgR by using polyclonal Nogo receptor antibodies (anti-NgRs) successfully blocked the inhibition of neurite outgrowth by Mag in a dose-dependent manner [109] . Hence, sustained delivery of anti-NgRs in the CNS after injury is effective in overcoming the growth inhibitory environment and promoting axonal regeneration. Our group first studied the controlled release of anti-NgRs via HA hydrogels [110] . The antibodies were conjugated to the HA backbone by a condensation reaction, with the amount of conjugated antibodies being 135 mg antibody per milligram hydrogel. The release was pH-dependent, with nearly 80 per cent of antibodies being released for up to 400 h in pH 7.4 buffer solution. Further in vitro experiments demonstrated that the condensation reaction did not compromise the bioactivity of anti-NgRs.
Based on the HA-based delivery system, the effect of controlled release of anti-NgRs via HA hydrogels was evaluated both in vitro and in vivo. In an in vitro study, release of anti-NgRs enhanced adhesion, viability and neurite extension of DRG on HA hydrogels [94] . As shown in figure 5a ,b, many more neurites were observed in groups with anti-NgRs than those without. This effect was more vividly shown by releasing anti-NgRs from a certain point and thus creating a concentration gradient of the antibodies. DRG neurites extended specifically towards where anti-NgRs were released, as shown in figure 5c.
Our group then investigated the effect of controlled release of anti-NgRs in a rat stroke model by using HA hydrogels [95] . In behavioural tests, 20 weeks after implantation, the groups with HA-anti-NgRs obtained all pellets in less attempts than the control with HA did, which indicated that the release of anti-NgRs improved functional recovery. The results well matched those of histochemical investigations. There are more nerve fibres and b-tubulin-III positive neurons in the HA-anti-NgR hydrogels than in negative controls, as shown in figure  6 . In an SCI model, similar results were observed, with few NF-positive fibres discovered in the implants without anti-NgRs, while several NF-positive axons were observed entering the HA-anti-NgR-PLL implants [96] . These in vivo results demonstrated that controlled delivery of antiNgRs supported axonal regeneration, which was of great potential for clinical applications.
3.4.2. Delivery of neurotrophic factors using hyaluronic acid-based scaffolds Park et al. [111] reported the effect of controlled release of BDNF both in vitro and in vivo by using HA hydrogels. BDNF was incorporated into HA hydrogels by electrostatic interaction. The release of BDNF significantly changed the morphology and gene expression of MSCs in culture. In a rat SCI model, HA implants with BDNF better promoted functional recovery as measured by Basso, Beattie and Bresnahan (BBB) scores. Hence, HA hydrogels had the potential to be ideal carriers of BDNF. Recently, our group reported the effect of using PLGA microspheres as carriers for growth factors [112] . VEGF and BDNF were incorporated into PLGA microspheres by a water-in-oil-in-water emulsion technique, and PLGA microspheres were distributed in HA solution before gelation. The release curves of this HA hydrogel/ PLGA microsphere composite began with an initial burst, followed by a stable release phase, with about 12 per cent of total loading released after 100 h.
Delivery of neural cells using hyaluronic acid-based scaffolds
On the basis of studies on the modifications and delivery of bioactive agents, HA hydrogels are investigated for the purpose of delivering neural cells to the lesion sites of the CNS, so as to facilitate axonal regeneration and functional recovery. The biocompatibility of HA hydrogels with different neural cells, namely was NPCs, hippocampal neurons and NSCs, was investigated.
After being cultured for 7 days, hippocampal neurons exhibited different morphologies on different HA hydrogels, as shown in figure 7 [113] . Neurons on hydrogels without modification remained rounded, while those on hydrogels modified with PLL or hydrogels cross-linked with anti-NgRs exhibited multi-polar morphology. In addition, neurons were more evenly distributed on hydrogels with both PLL and NgR. Interestingly, NPCs were observed to behave similarly on these hydrogels [114] . Our recent work focuses on the delivery of NSCs via HA-based scaffolds. The adhesion of NSCs to HA hydrogels is shown in figure 8 . The modifications with PLL and the delivery of anti-NgRs helped neurospheres to attach to and spread on HA hydrogels. Incorporation of PLGA microspheres encapsulating VEGF and BDNF further promoted NSC adhesion and proliferation [112] . After 5 days of culture, neurites extended along the wall of the scaffold and formed an extensive network (figure 9). The proliferation assay showed that NSCs on the HA hydrogel with growth-factor-containing PLGA microspheres grew faster than negative controls. In our latest work, the NSC-HA-PLL-anti-NgR complex was implanted into infarction lesions of rat brain and its capability to induce neural regeneration was evaluated. Our results showed that NSCs within the HA scaffolds were able to stay alive for up to 24 weeks after implantation. The most inspiring result was that 10 weeks after implantation, both synapse formation and expression of synaptophysin were observed. Since synaptophysin is the marker of synapse regeneration, its presence suggested that neurons derived from grafted NSCs formed synapses and began to reconstruct nervous circuits, which was an important step towards functional recovery.
CONCLUDING REMARKS
By developing a materials-based system containing biomaterials, regulators and cells, great progress has been made in promoting CNS regeneration in recent years. The integration of different factors overcomes the multi-faceted inhibitory environment in the CNS after injury and successfully facilitates infiltration of cells, formation of nerve fibres and blood vessels, and finally functional recovery. In recent years, HA hydrogels have been extensively studied as a candidate for repairing CNS injuries. Owing to its unique properties, HA significantly reduced glial scar formation after implantation to lesion sites, which makes it attractive in designing and fabricating scaffolds for CNS regeneration. Different ECM components have been applied to modify HA hydrogels, aiming at enhancing axonal regrowth. The controlled release of anti-NgRs further enhances the regeneration of nerve fibres into the scaffolds. Combining with ECM modification and release of antibodies, HA-based scaffolds are investigated in neural cell culture, showing that HA-based scaffolds are highly biocompatible. Further in vivo studies find the existence of synaptophysin and formation of synapses. Thus, HAbased scaffolds have great potential for use in central neural tissue engineering.
To date, there is still no widely accepted therapy that is capable of achieving complete functional recovery.
Despite some inspiring results, such as axonal growth into the distal ends, myelination of new nerve fibres and formation of synapses, only partial functional recovery is observed, and in the long term, scaffolds in fact do not make a difference in functional recovery as observed by BBB scores. This is confirmed by the finding that 1 year after implantation the number of regenerative axon fibres is much less than that of axons in spared tissues [49] . Hence, there is still a long way to go.
Future design and fabrication of scaffolds for CNS regeneration will certainly focus on development of a materials-based system integrating different strategies of design and fabrication of scaffolds, delivery of bioactive agents and cells to trigger intrinsic selfregenerative ability. Scaffolds of hybrids or composites, which are made from blending of different kinds of electrospun nanofibres, or made of hydrogel -electrospun fibre composites, may have some unexpected properties in influencing cell behaviour and directing cell migration. In co-culture systems, different combinations of supporting cells and pluripotent cells may result in specific control over lineage of pluripotent cells, especially when combinations of growth factors are present. Scaffolds with special designer gradients of growth factors or ECM components may outperform in directing axonal outgrowth and promoting functional recovery. Although regeneration of the injured CNS is challenging, it is promising that integration of scaffolds, regulators and cells will provide auspicious therapies to achieve a complete recovery of CNS injuries. Review. HA-based scaffold for CNS regeneration X. Wang et al. 287
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